Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2

Hilton, S; Naud, S; Caldwell, JJ; Boxall, K; Burns, S; Anderson, VE; Antoni, L; Allen, CE; Pearl, LH; Oliver, AW; Wynne Aherne, G; Garrett, MD; Collins, I

HERO ID

1466693

Reference Type

Journal Article

Year

2010

Language

English

PMID

20022510

HERO ID 1466693
In Press No
Year 2010
Title Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2
Authors Hilton, S; Naud, S; Caldwell, JJ; Boxall, K; Burns, S; Anderson, VE; Antoni, L; Allen, CE; Pearl, LH; Oliver, AW; Wynne Aherne, G; Garrett, MD; Collins, I
Journal Bioorganic & Medicinal Chemistry
Volume 18
Issue 2
Page Numbers 707-718
Abstract 5-(Hetero)aryl-3-(4-carboxamidophenyl)-2-aminopyridine inhibitors of CHK2 were identified from high throughput screening of a kinase-focussed compound library. Rapid exploration of the hits through straightforward chemistry established structure-activity relationships and a proposed ATP-competitive binding mode which was verified by X-ray crystallography of several analogues bound to CHK2. Variation of the 5-(hetero)aryl substituent identified bicyclic dioxolane and dioxane groups which improved the affinity and the selectivity of the compounds for CHK2 versus CHK1. The 3-(4-carboxamidophenyl) substituent could be successfully replaced by acyclic omega-aminoalkylamides, which made additional polar interactions within the binding site and led to more potent inhibitors of CHK2. Compounds from this series showed activity in cell-based mechanistic assays for inhibition of CHK2.
Doi 10.1016/j.bmc.2009.11.058
Pmid 20022510
Wosid WOS:000273613500023
Is Certified Translation No
Dupe Override No
Comments Source: Web of Science WOS:000273613500023
Is Public Yes
Language Text English
Keyword CHK2; Kinase inhibitor; High-throughput screening; Crystallography